• Full Text
    • Scholarly Journal

    Targeted Degradation Technologies Utilizing Autophagy

    ; 
    ; 
    ; 
    ; 
    ; et al. 
    ; 
    ; 
    ; 
    ; 
    ; 
    ; 
    ; 
    ; 
    ; 
    ; View all authors. 
    ; Basel Vol. 26, Iss. 14,  (2025): 6576.     DOI:10.3390/ijms26146576
    PDF CiteCite
    Copy URLPrintAll Options

    References (75)

    • 1.

      The role of p53 in cell cycle regulation

      PH Shaw. Pathol Res Pract Vol. 192, .
    • 3.

      Targeted degradation of membrane and extracellular proteins with LYTACs

      Li, Yu-Yang; Yang, Yang; Zhang, Ren-Shuai; Ge, Rui-Xin; Xie, Song-Bo.  Acta pharmacologica Sinica Vol. 46, Iss. 1,  (Jan 2025): 1-7.
    • 4.

      Discovery of Novel PDEdelta Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC)

      J. Bao; Z. Chen; Y. Li; L. Chen; W. Wang; C. Sheng; G. Dong. ACS Med. Chem. Lett Vol. 15, (2024).
    • 5.

      Targeted Degradation of Cell-Surface Proteins via Chaperone-Mediated Autophagy by Using Peptide-Conjugated Antibodies

      J. Shao; X. Lin; H. Wang; C. Zhao; S.Q. Yao; J. Ge; S. Zeng; L. Qian. Angew. Chem. Int. Ed. Engl Vol. 63, (2024).
    • 6.

      DDHD2, whose mutations cause spastic paraplegia type 54, enhances lipophagy via engaging ATG8 family proteins

      F Jia; X Wang; Y Fu; S-M Zhao; B Lu; C Wang. Cell Death Differ Vol. 31, (2024): 348-359.
    • 7.

      Targeting EGFR degradation by autophagosome degraders

      Z. Zhu; J. Li; S. Shen; H. Al-Furas; S. Li; Y. Tong; Y. Li; Y. Zeng; Q. Feng; K. Chen. Eur. J. Med. Chem Vol. 270, (2024).
    • 8.

      Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies

      H. Tong; T. Yang; S. Xu; X. Li; L. Liu; G. Zhou; S. Yang; S. Yin; X.J. Li; S. Li. Int. J. Mol. Sci Vol. 25, (2024).
    • 9.

      Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors

      X Huang. Nat. Nanotechnol(2024).
    • 10.

      Extracellular targeted protein degradation: an emerging modality for drug discovery

      JA Wells; K Kumru. Nat. Rev. Drug Discov Vol. 23, (2024): 126-140.
    • 11.

      Targeting the Undruggables-the Power of Protein Degraders

      C. Zhang; Y. Liu; G. Li; Z. Yang; C. Han; X. Sun; C. Sheng; K. Ding; Y. Rao. Sci. Bull Vol. 69, (2024).
    • 12.

      Bioorthogonal Aptamer-ATTEC Conjugates for Degradation of Alpha-Synuclein via Autophagy-Lysosomal Pathway

      X. Liao; G. Qin; Z. Liu; J. Ren; X. Qu. Small Vol. 20, (2024).
    • 13.

      Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer

      Y. Lu; Y. Yang; G. Zhu; H. Zeng; Y. Fan; F. Guo; D. Xu; B. Wang; D. Chen; G. Ge. Int. J. Biol. Sci Vol. 19, (2023).
    • 14.

      ATNC: Versatile Nanobody Chimeras for Autophagic Degradation of Intracellular Unligandable and Undruggable Proteins

      H. He; C. Zhou; X. Chen. J. Am. Chem. Soc Vol. 145, (2023).
    • 15.

      Second-generation AUTACs for targeted autophagic degradation

      D Takahashi. J. Med. Chem Vol. 66, (2023): 12342-12372.
    • 16.

      Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology

      J Lee; KW Sung; EJ Bae; D Yoon; D Kim; JS Lee; DH Park; DY Park; SR Mun; SC Kwon; HY Kim; JO Min; SJ Lee; YH Suh; YT Kwon. Mol Neurodegener Vol. 18, Iss. 1, (2023).
    • 17.

      Autophagy and Autophagy‐Related Pathways in Cancer

      J Debnath; N Gammoh; K M Ryan. Nature Reviews Molecular Cell Biology Vol. 24, Iss. 8, (2023): 560-575.
    • 18.

      Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects

      S. Tan; D. Wang; Y. Fu; H. Zheng; Y. Liu; B. Lu. Sci. Bull Vol. 68, (2023).
    • 19.

      Manipulating autophagic degradation in human diseases: from mechanisms to interventions

      Zhang, Yiqing; Liu, Xiaoxia; Klionsky, Daniel J; Lu, Boxun; Zhong, Qing.  Life Medicine; Beijing Vol. 1, Iss. 2,  (Oct 2022): 120-148.
    • 20.

      Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands

      Zhao, Hong-Yi; Wang, Hai-Peng; Mao, Yu-Ze; Zhang, Hao; Xin, Minhang; et al.  JOURNAL OF MEDICINAL CHEMISTRY Vol. 65, Iss. 6,  (Mar 2022).